Competitive Technologies launches noninvasive pain therapy in US
This article was originally published in Clinica
Executive Summary
Competitive Technologies (CTT) has launched its Calmare pain management device in the US. The system, which uses electrodes that are applied to the surface of the skin, is now available at Calmar Pain Relief's Pain Therapy Center in North Providence, Rhode Island for treating high-intensity oncologic and neuropathic pain. It transmits "non-pain" information rather than blocking pain transmission, and avoids the side-effects associated with narcotic painkillers, including addiction. Calmar plans to open similar clinics in 10 more US cities in the next 24 months. The device has received 510(k) clearance from the US FDA and is CE marked for sale in Europe. CTT estimates that the global pain market will reach $40bn this year.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.